scispace - formally typeset
Journal ArticleDOI

Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.

Aparna Schweitzer, +4 more
- 17 Oct 2015 - 
- Vol. 386, Iss: 10003, pp 1546-1555
Reads0
Chats0
TLDR
This first global assessment of country-level population prevalence of chronic HBV infection found a wide variation between countries and highlights the need for continued prevention and control strategies and the collection of reliable epidemiologic data using standardised methodology.
About: 
This article is published in The Lancet.The article was published on 2015-10-17. It has received 2130 citations till now. The article focuses on the topics: HBsAg & Hepatitis B virus.

read more

Citations
More filters
Journal ArticleDOI

New therapeutic agents for chronic hepatitis B

Mayur Brahmania, +4 more
- 01 Feb 2016 - 
TL;DR: This Review provides a summary of available regimens with their strengths and limitations, and highlights future therapeutic strategies to target the virus and host immune response.
Journal ArticleDOI

The microRNA‐99 family modulates hepatitis B virus replication by promoting IGF‐1R/PI3K/Akt/mTOR/ULK1 signaling‐induced autophagy

Yong Lin, +8 more
- 01 May 2017 - 
TL;DR: Experimental data demonstrated that the miR‐99 family promoted autophagy through mTOR/ULK1 signaling and thereby enhanced hepatitis B virus replication and promotes HBV replication posttranscriptionally through IGF‐1R/PI3K/Akt/mTOR/ulk1 signaling‐inducedAutophagy.
Journal ArticleDOI

Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial).

Mamun Al Mahtab, +8 more
- 22 Aug 2018 - 
TL;DR: Nasvac induced a superior reduction of the viral load under the limit of detection compared to Peg-IFN treatment, and is a safe and efficacious finite alternative of antiviral treatment for CHB patients.
Journal ArticleDOI

Safety and efficacy of vesatolimod (GS-9620) in patients with chronic hepatitis B who are not currently on antiviral treatment.

Kosh Agarwal, +13 more
- 22 Aug 2018 - 
TL;DR: Overall, vesatolimod is safe and well tolerated in CHB patients and consistent dose‐dependent pharmacodynamic induction of ISGs was demonstrated, and it did not result in clinically significant HBsAg decline.
Journal ArticleDOI

Comparison of clinical practice guidelines for the management of chronic hepatitis b: When to start, when to change, and when to stop

Hyung Joon Yim, +9 more
- 28 Aug 2020 - 
TL;DR: This review compares the similarities and differences among the various practice guidelines for the management of chronic hepatitis B to identify unmet needs and improve future recommendations.
References
More filters
Journal Article

R: A language and environment for statistical computing.

R Core Team
- 01 Jan 2014 - 
TL;DR: Copyright (©) 1999–2012 R Foundation for Statistical Computing; permission is granted to make and distribute verbatim copies of this manual provided the copyright notice and permission notice are preserved on all copies.
Journal ArticleDOI

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

David Moher, +4 more
- 21 Jul 2009 - 
TL;DR: Moher et al. as mentioned in this paper introduce PRISMA, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses, which is used in this paper.
Journal Article

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.

David Moher, +4 more
- 21 Jul 2009 - 
TL;DR: The QUOROM Statement (QUality Of Reporting Of Meta-analyses) as mentioned in this paper was developed to address the suboptimal reporting of systematic reviews and meta-analysis of randomized controlled trials.
Journal ArticleDOI

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

David Moher, +4 more
- 01 Jan 2010 - 
TL;DR: A structured summary is provided including, as applicable, background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions and implications of key findings.
Journal ArticleDOI

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

Mohsen Naghavi, +731 more
- 10 Jan 2015 - 
TL;DR: In the Global Burden of Disease Study 2013 (GBD 2013) as discussed by the authors, the authors used the GBD 2010 methods with some refinements to improve accuracy applied to an updated database of vital registration, survey, and census data.
Related Papers (5)

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.

Pietro Lampertico, +7 more
- 01 Aug 2017 - 

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Shiv Kumar Sarin, +32 more
- 01 Jan 2016 - 

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

Norah A. Terrault, +8 more
- 01 Apr 2018 - 

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

Chien-Jen Chen, +7 more
- 04 Jan 2006 - 

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Rafael Lozano, +195 more
- 15 Dec 2012 -